At Accenture, our expert teams in operations, technology and consulting support the entire pharmacovigilance journey, from proof-of-concept to end-to-end services. We have more than 1,200 dedicated pharmacovigilance resources, including 60 physicians and 45 medical writers, who are helping our clients process 1.5 million cases annually. We offer a pharmacovigilance technology platform solution that helps our life sciences clients reduce manual effort in individual case safety reports (ICSRs) processing. By combining artificial intelligence technologies with skilled human workers and smart processes, our life sciences clients can more effectively advance discovery, manage drug development and deliver solutions that will make a difference in patients’ lives.
